JIMMY MASCARO: Open Payments
NPI 1104998251 · OTTUMWA, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$105,768 in 163 payments from 6 companies in 2025. Trend: 2023 $45,063 · 2024 $36,554 · 2025 $105,768
Speaker / faculty: $87,160Travel & lodging: $12,547Food & beverage: $4,221Consulting: $1,840
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 131 | $90,098 |
| ABBVIE INC. | 19 | $13,296 |
| E.R. Squibb & Sons, L.L.C. | 1 | $1,840 |
| Otsuka America Pharmaceutical, Inc. | 8 | $418 |
| Lundbeck LLC | 3 | $99 |
| Axsome Therapeutics, Inc. | 1 | $18 |
Products named: FANAPT, VRAYLAR, ABILIFY MAINTENA, REXULTI, ABILIFY ASIMTUFII, Auvelity.
Industry payments across IA — which companies pay providers there.
